FTUS
AEON.WS

Flow Traders U.S.’s AEON Biopharma Inc AEON.WS Stock Holding History

Flow Traders U.S.’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,461
Closed -$1K – 1152
2023
Q4 		$1K Sell
10,461
-3,837
-27% -$286 ﹤0.01% 789
2023
Q3 		$2K Buy
+14,298
New +$2.03K ﹤0.01% 796
2023
Q2 		– Sell
-39,983
Closed -$2K – 1159
2023
Q1 		$2K Buy
39,983
+12,123
+44% +$699 ﹤0.01% 812
2022
Q4 		$1K Buy
27,860
+11,128
+67% +$450 ﹤0.01% 782
2022
Q3 		$1K Buy
+16,732
New +$1.53K ﹤0.01% 929

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Flow Traders U.S.'s AEON.WS Position: Q1 2024 in Review

Flow Traders U.S. sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 10,461 shares — an estimated $1K sold.

Flow Traders U.S. first reported a position in AEON.WS in Q3 2022 and held it in 5 quarters. The position peaked at $2K in Q3 2023. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Flow Traders U.S. reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Flow Traders U.S. sold 10,461 AEON Biopharma Inc shares in Q1 2024, an estimated $1K.
  • Flow Traders U.S. first reported a position in AEON Biopharma Inc in Q3 2022 and held it in 5 quarters.
  • Flow Traders U.S.'s AEON Biopharma Inc position peaked at $2K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Flow Traders U.S.'s 13F filing for Q1 2024, filed 15 May 2024.